X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

PMCB

Closed

Pharmacyte Biotech Inc

1.14
+0.05 (+4.59%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.09
Day's Range: 1.09 - 1.15
Send
When Written:
 
2.93
PharmaCyte Biotech Inc is a biotechnology company that focuses on developing and commercializing cell-based therapies for cancer and diabetes. The company's proprietary technology, called Cell-in-a-Box, is a platform that encapsulates living cells in a protective capsule, allowing for targeted delivery of therapeutic agents to specific areas of the body.

PharmaCyte Biotech's lead product candidate is a treatment for advanced pancreatic cancer using the Cell-in-a-Box technology. The company is also developing treatments for other types of cancer, as well as diabetes.

Founded in 1996, PharmaCyte Biotech is headquartered in Silver Spring, Maryland, and has research and development facilities in Australia. The company is publicly traded on the OTCQB market under the ticker symbol PMCB.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X